erythromycin has been researched along with juglone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
| Bakhrouf, A; Ben Slama, R; Chaabouni, Y; Chaieb, K; Kouidhi, B; Mahdouani, K; Miladi, H; Zmantar, T | 1 |
2 other study(ies) available for erythromycin and juglone
| Article | Year |
|---|---|
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |
Use of juglone as antibacterial and potential efflux pump inhibitors in Staphylococcus aureus isolated from the oral cavity.
Topics: Anti-Bacterial Agents; Benzalkonium Compounds; Biological Transport, Active; Child; Disinfectants; Drug Synergism; Enzyme Inhibitors; Erythromycin; Ethidium; Humans; Microbial Sensitivity Tests; Mouth; Naphthoquinones; Staphylococcus aureus; Tetracycline; Tunisia | 2016 |